Acetazolamide sensitive tissue calcification and aging of klotho-hypomorphic mice

Journal of Molecular Medicine

Volumn 94, Issue 1, 2016, Pages 95-106

  Leibrock, Christina B ^a   Alesutan, Ioana ^a   Voelkl, Jakob ^a   Michael, Diana ^a   Castor, Tatsiana ^a   Kohlhofer, Ursula ^a   Quintanilla Martinez, Leticia ^a   Kübler, Laura ^a   Mannheim, Julia G ^a   Pichler, Bernd J ^a   Rosenblatt, Kevin P ^b   Kuro o, Makoto ^c   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

1,25(OH)2D3; Acetazolamide; Acidosis; Calcification; Calcium; Phosphate

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; ACETAZOLAMIDE; ALDOSTERONE; ALKALINE PHOSPHATASE; BICARBONATE; CALCIUM; CYSTATIN C; FETUIN A; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; MESSENGER RNA; OSTEOPONTIN; OSTEOPROTEGERIN; PARATHYROID HORMONE; PHOSPHATE; UREA; VASOPRESSIN; BETA GLUCURONIDASE; CALCITRIOL; CARBONATE DEHYDRATASE INHIBITOR;

ACIDOSIS; AGE; AGING; ALDOSTERONE BLOOD LEVEL; ALKALINITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD CARBON DIOXIDE TENSION; BLOOD PH; BLOOD VESSEL CALCIFICATION; BODY WEIGHT; CALCIFICATION; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM URINE LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; ENTEROPATHY; FLUID INTAKE; FOOD INTAKE; GENOTYPE; HUMAN; HUMAN CELL; INTESTINE CALCIFICATION; KIDNEY CALCIFICATION; KIDNEY FUNCTION; LIFESPAN; LUNG CALCIFICATION; MALE; MOUSE; NONHUMAN; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; SMOOTH MUSCLE FIBER; SOFT TISSUE CALCIFICATION; SURVIVAL; TRACHEA CALCIFICATION; UPREGULATION; UREA BLOOD LEVEL; URINARY EXCRETION; URINE PH; VASOPRESSIN BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; BLOOD; BONE DEVELOPMENT; CELL CULTURE; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; HYPERPHOSPHATEMIA; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; VASCULAR CALCIFICATION;

ACETAZOLAMIDE; ACIDOSIS; AGING; ALKALINE PHOSPHATASE; ANIMALS; CALCITRIOL; CALCIUM; CARBONIC ANHYDRASE INHIBITORS; CELLS, CULTURED; GLUCURONIDASE; HUMANS; HYPERPHOSPHATEMIA; MICE; MICE, KNOCKOUT; OSTEOGENESIS; PHOSPHATES; SIGNAL TRANSDUCTION; VASCULAR CALCIFICATION;

EID: 84953635144     PISSN: 09462716     EISSN: 14321440     Source Type: Journal    
DOI: 10.1007/s00109-015-1331-x     Document Type: Article

References (50)

1. Tsujikawa H, Kurotaki Y, Fujimori T, Fukuda K, Nabeshima Y (2003) Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 17:2393–2403
2. Imura A, Iwano A, Tohyama O, Tsuji Y, Nozaki K, Hashimoto N, Fujimori T, Nabeshima Y (2004) Secreted Klotho protein in sera and CSF: implication for post-translational cleavage in release of Klotho protein from cell membrane. FEBS Lett 565:143–147
3. Feger M, Fajol A, Lebedeva A, Meissner A, Michael D, Voelkl J, Alesutan I, Schleicher E, Reichetzeder C, Hocher B et al (2013) Effect of carbon monoxide donor CORM-2 on vitamin D3 metabolism. Kidney Blood Press Res 37:496–505
4. Ramasamy I (2006) Recent advances in physiological calcium homeostasis. Clin Chem Lab Med 44:237–273
5. Segawa H, Yamanaka S, Ohno Y, Onitsuka A, Shiozawa K, Aranami F, Furutani J, Tomoe Y, Ito M, Kuwahata M et al (2007) Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice. Am J Physiol Renal Physiol 292:F769–F779
6. Topala CN, Bindels RJ, Hoenderop JG (2007) Regulation of the epithelial calcium channel TRPV5 by extracellular factors. Curr Opin Nephrol Hypertens 16:319–324
7. Hu MC, Shi M, Zhang J, Pastor J, Nakatani T, Lanske B, Razzaque MS, Rosenblatt KP, Baum MG, K-o M et al (2010) Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule. FASEB J 24:3438–3450
8. Imura A, Tsuji Y, Murata M, Maeda R, Kubota K, Iwano A, Obuse C, Togashi K, Tominaga M, Kita N et al (2007) alpha-Klotho as a regulator of calcium homeostasis. Science 316:1615–1618
9. Kuro-o M (2013) Klotho, phosphate and FGF-23 in ageing and disturbed mineral metabolism. Nat Rev Nephrol 9:650–660
10. Hu MC, Shi M, Zhang J, Quinones H, Griffith C, Kuro-o M, Moe OW (2011) Klotho deficiency causes vascular calcification in chronic kidney disease. J Am Soc Nephrol 22:124–136
11. Kawaguchi H, Manabe N, Chikuda H, Nakamura K, Kuroo M (2000) Cellular and molecular mechanism of low-turnover osteopenia in the klotho-deficient mouse. Cell Mol Life Sci 57:731–737
12. Yuan Q, Sato T, Densmore M, Saito H, Schuler C, Erben RG, Lanske B (2012) Deletion of PTH rescues skeletal abnormalities and high osteopontin levels in Klotho−/− mice. PLoS Genet 8, e1002726
13. Fischer SS, Kempe DS, Leibrock CB, Rexhepaj R, Siraskar B, Boini KM, Ackermann TF, Foller M, Hocher B, Rosenblatt KP et al (2010) Hyperaldosteronism in Klotho-deficient mice. Am J Physiol Renal Physiol 299:F1171–F1177
14. Voelkl J, Alesutan I, Leibrock CB, Quintanilla-Martinez L, Kuhn V, Feger M, Mia S, Ahmed MS, Rosenblatt KP, Kuro OM et al (2013) Spironolactone ameliorates PIT1-dependent vascular osteoinduction in klotho-hypomorphic mice. J Clin Invest 123:812–822
15. Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, Ohyama Y, Kurabayashi M, Kaname T, Kume E et al (1997) Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature 390:45–51
16. Kurosu H, Yamamoto M, Clark JD, Pastor JV, Nandi A, Gurnani P, McGuinness OP, Chikuda H, Yamaguchi M, Kawaguchi H et al (2005) Suppression of aging in mice by the hormone Klotho. Science 309:1829–1833
17. Yonova D (2009) Vascular calcification and metabolic acidosis in end stage renal disease. Hippokratia 13:139–140
18. Mendoza FJ, Lopez I, Montes DO, Perez J, Rodriguez M, Aguilera-Tejero E (2008) Metabolic acidosis inhibits soft tissue calcification in uremic rats. Kidney Int 73:407–414
19. Villa-Bellosta R, Sorribas V (2010) Compensatory regulation of the sodium/phosphate cotransporters NaPi-IIc (SCL34A3) and Pit-2 (SLC20A2) during Pi deprivation and acidosis. Pflugers Arch 459:499–508
20. Jara A, Felsenfeld AJ, Bover J, Kleeman CR (2000) Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease. Kidney Int 58:1023–1032
21. Jara A, Chacon C, Ibaceta M, Valdivieso A, Felsenfeld AJ (2004) Effect of ammonium chloride and dietary phosphorus in the azotaemic rat. I. Renal function and biochemical changes. Nephrol Dial Transplant 19:1986–1992
22. Ambuhl PM, Zajicek HK, Wang H, Puttaparthi K, Levi M (1998) Regulation of renal phosphate transport by acute and chronic metabolic acidosis in the rat. Kidney Int 53:1288–1298
23. Loniewski I, Wesson DE (2014) Bicarbonate therapy for prevention of chronic kidney disease progression. Kidney Int 85:529–535
24. Torres VE, Mujwid DK, Wilson DM, Holley KH (1994) Renal cystic disease and ammoniagenesis in Han:SPRD rats. J Am Soc Nephrol 5:1193–1200
25. Dobre M, Rahman M, Hostetter TH (2014) Current Status of Bicarbonate in CKD. J Am Soc Nephrol doi:10.1681/ASN.2014020205
26. De Marchi S, Cecchin E (1990) Severe metabolic acidosis and disturbances of calcium metabolism induced by acetazolamide in patients on haemodialysis. Clin Sci (Lond) 78:295–302
27. Schwenk MH, St Peter WL, Meese MG, Singhal PC (1995) Acetazolamide toxicity and pharmacokinetics in patients receiving hemodialysis. Pharmacotherapy 15:522–527
28. Leibrock CB, Alesutan I, Voelkl J, Pakladok T, Michael D, Schleicher E, Kamyabi-Moghaddam Z, Quintanilla-Martinez L, Kuro OM, Lang F (2015) NH4Cl treatment prevents tissue calcification in klotho deficiency. J Am Soc Nephrol. doi:10.1681/ASN.2014030230
29. Han MS, Che X, Cho GH, Park HR, Lim KE, Park NR, Jin JS, Jung YK, Jeong JH, Lee IK et al (2013) Functional cooperation between vitamin D receptor and Runx2 in vitamin D-induced vascular calcification. PLoS One 8, e83584
30. Biber J, Hernando N, Forster I, Murer H (2009) Regulation of phosphate transport in proximal tubules. Pflugers Arch 458:39–52
31. Disthabanchong S, Radinahamed P, Stitchantrakul W, Hongeng S, Rajatanavin R (2007) Chronic metabolic acidosis alters osteoblast differentiation from human mesenchymal stem cells. Kidney Int 71:201–209
32. Brandao-Burch A, Utting JC, Orriss IR, Arnett TR (2005) Acidosis inhibits bone formation by osteoblasts in vitro by preventing mineralization. Calcif Tissue Int 77:167–174
33. Murshed M, McKee MD (2010) Molecular determinants of extracellular matrix mineralization in bone and blood vessels. Curr Opin Nephrol Hypertens 19:359–365
34. Leaf DE, Goldfarb DS (2007) Mechanisms of action of acetazolamide in the prophylaxis and treatment of acute mountain sickness. J Appl Physiol 102:1313–1322
35. Kapustin A, Shanahan CM (2009) Targeting vascular calcification: softening-up a hard target. Curr Opin Pharmacol 9:84–89
36. Coladonato JA (2005) Control of hyperphosphatemia among patients with ESRD. J Am Soc Nephrol 16(Suppl 2):S107–S114
37. Kalantar-Zadeh K, Shah A, Duong U, Hechter RC, Dukkipati R, Kovesdy CP (2010) Kidney bone disease and mortality in CKD: revisiting the role of vitamin D, calcimimetics, alkaline phosphatase, and minerals. Kidney Int Suppl: S10-S21
38. Kadoglou NP, Kottas G, Lampropoulos S, Vitta I, Liapis CD (2014) Serum levels of fetuin-a, osteoprotegerin and osteopontin in patients with coronary artery disease: effects of statin (HMGCoA-reductase inhibitor) therapy. Clin Drug Investig 34:165–171
39. Scialla JJ, Kao WH, Crainiceanu C, Sozio SM, Oberai PC, Shafi T, Coresh J, Powe NR, Plantinga LC, Jaar BG et al (2014) Biomarkers of vascular calcification and mortality in patients with ESRD. Clin J Am Soc Nephrol. doi:10.2215/CJN.05450513
40. Takeuchi S, Hirukawa K, Togari A (2013) Acidosis inhibits mineralization in human osteoblasts. Calcif Tissue Int 93:233–240
41. Frick KK, Bushinsky DA (1999) In vitro metabolic and respiratory acidosis selectively inhibit osteoblastic matrix gene expression. Am J Physiol 277:F750–755
42. Sage AP, Tintut Y, Demer LL (2010) Regulatory mechanisms in vascular calcification. Nat Rev Cardiol 7:528–536
43. Buso G, Faggin E, Pauletto P, Rattazzi M (2014) Osteoprotegerin in cardiovascular disease:ally or enemy? Curr Pharm Des 20(37):5862–9
44. Callegari A, Coons ML, Ricks JL, Rosenfeld ME, Scatena M (2014) Increased calcification in osteoprotegerin-deficient smooth muscle cells: dependence on receptor activator of NF-kappaB ligand and interleukin 6. J Vasc Res 51:118–131
45. Lund SA, Giachelli CM, Scatena M (2009) The role of osteopontin in inflammatory processes. J Cell Commun Signal 3:311–322
46. Alexander RT, Woudenberg-Vrenken TE, Buurman J, Dijkman H, van der Eerden BC, van Leeuwen JP, Bindels RJ, Hoenderop JG (2009) Klotho prevents renal calcium loss. J Am Soc Nephrol 20:2371–2379
47. Nijenhuis T, Renkema KY, Hoenderop JG, Bindels RJ (2006) Acid–base status determines the renal expression of Ca2+ and Mg2+ transport proteins. J Am Soc Nephrol 17:617–626
48. Eknoyan G, Suki WN, Martinez-Maldonado M (1970) Effect of diuretics on urinary excretion of phosphate, calcium, and magnesium in thyroparathyroidectomized dogs. J Lab Clin Med 76:257–266
49. Sinha TK, Allen DO, Queener SF, Bell NH, Larson S, McClintock R (1977) Effects of acetazolamide on the renal excretion of phosphate in hypoparathyroidism and pseudohypoparathyroidism. J Lab Clin Med 89:1188–1197
50. Mossbrugger I, Hoelzlwimmer G, Calzada-Wack J, Quintanilla-Martinez L (2007) Standardized morphological phenotyping of mouse models of human diseases within the German Mouse Clinic. Verh Dtsch Ges Pathol 91:98–103